Navigation Links
PRIM&R Announces Longtime Leader to Step Down
Date:5/1/2013

BOSTON, May 1, 2013 /PRNewswire-USNewswire/ -- Public Responsibility in Medicine and Research (PRIM&R), an organization at the forefront of educating and engaging the public and the research community on the ethics of biomedical, social science, and behavioral research, has announced that its founding executive director, Joan Rachlin , will step down in early 2014 from the position she has held since 1975.

Since its founding in 1974, PRIM&R has grown to be among the most respected and valued voices for keeping ethics and scientific responsibility at the center of biomedical and behavioral research. During Ms. Rachlin's nearly 40-year tenure, PRIM&R has become a globally respected organization with 4,000 members from around the world.   

"Joan's matchless leadership transformed the dream of several Boston-area researchers to advance ethical research into an inspiring reality. Her steady guidance has been a beacon in the field, and her personal dedication and warmth have made PRIM&R the essential venue in research ethics," said Alexander Capron , LLB, Chair of PRIM&R's Board of Directors and the Scott H. Bice Chair in Healthcare Law, Policy, and Ethics at the University of Southern California. 

Under Ms. Rachlin's stewardship, PRIM&R has become a forum for stakeholders to discuss ethical issues and best practices, and address controversies in the ever-changing field of research with human beings and animals. Additionally, PRIM&R's innovative and high quality educational programs have prepared researchers and research ethics committee members and staff for the difficult task of ensuring that ethical considerations are integrated into the review of all protocols.  

"Leaving such a best-of-all-possible-worlds job will not be easy, but now seems like the right time for both PRIM&R and me to take this step in our respective journeys. I have such confidence in PRIM&R's strength and its ongoing critical role in the future of research, largely because our Board is wise and hardworking, our staff incomparable, and our community strong and committed," Ms. Rachlin said. 

A health lawyer by training, Ms. Rachlin developed programs on the ethical oversight of research that have provided critical information and skill-building tools to thousands of researchers and research oversight professionals in the US and abroad. Among the topics she helped bring to audiences were the treatment of vulnerable populations in research, HIV/AIDS studies, scientific misconduct, conflicts of interest, privacy and confidentiality, and the competencies of institutional review boards and institutional animal care and use committees.

"Largely because of Joan's passion, commitment, and hard work, PRIM&R has become a unique and respected resource for the individuals and institutions responsible for the ethical conduct of research," said Joseph Byrne , Associate Provost for Research Emeritus at Tufts University, and one of PRIM&R's founders who hired Ms. Rachlin in 1975.

The Board of Directors has initiated a search for Ms. Rachlin's successor. The Search Committee, chaired by Board member Dr. Cynthia A. Gómez , Director of the Heath Equity Institute at San Francisco State University, will announce further details in May.

Contact: Kimberly Hensle Lowrance at khensle@primr.org; 617.423.4112, ext. 119


'/>"/>
SOURCE Public Responsibility in Medicine and Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Announces Record First Quarter 2013 Results
2. ViroPharma Announces First Quarter 2013 Financial Results
3. PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy
4. SoundConnect Announces Lync Release in the United States
5. Save The Cord Foundation, a Global Leader in Cord Blood Advocacy, Announces its Expansion of Educational Information Surrounding Other Non-Controversial Stem Cell Sources
6. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.
7. Probiotic Action Announces the Use of Their Acne Treatment for All types of Skin
8. Robert Lowen MD, Expert Bay Area Plastic Surgeon, Announces Cutting-Edge 3-D Crisalix Imaging Technology to Aid Patients in Choosing their Breast Implant Size
9. Micropharma announces timeline to commercial launch of worlds first ingestible gastrointestinal sampling device
10. Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
11. Probiotic Acne Treatment, Probiotic Action Announces Revolutionary Portable Acne Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 On Thursday, March 23, ... 5,817.69, down 0.07%; the Dow Jones Industrial Average edged ... 500 closed at 2,345.96, marginally dropping 0.11%. US markets ... green, 4 sectors finished in red, and 1 sector ... initiated reports coverage on the following Biotechnology equities: BioDelivery ...
(Date:3/23/2017)... -- Research and Markets has announced the addition ... their offering. ... The Global Market for Bioproducts Should Reach $714.6 ... CAGR of 8.9%, This research report quantifies ... major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... selected by the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® ... annual Women of Innovation Awards Dinner. , The dinner recognizes women accomplished in ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
Breaking Biology Technology:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
Breaking Biology News(10 mins):